[Review [new antibiotics series IV]: latamoxef (author's transl)].
D000328:Adult; D000818:Animals; D001424:Bacterial Infections / Q000188:drug therapy; D002511:Cephalosporins / Q000627:therapeutic use*; D002513:Cephamycins / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D002675:Child, Preschool; D004285:Dogs; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D051379:Mice; D009070:Moxalactam; D011817:Rabbits; D051381:Rats
D002511:Cephalosporins; D002513:Cephamycins; D009070:Moxalactam